Verition Fund Management
IART icon

Verition Fund Management’s Integra LifeSciences IART Stock Holding History

Verition Fund Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-17,116
Closed -$161K – 2286
2026
Q1 		$161K Sell
17,116
-78,938
-82% -$867K ﹤0.01% 1984
2025
Q4 		$1.19M Buy
96,054
+65,647
+216% +$873K ﹤0.01% 2016
2025
Q3 		$436K Sell
30,407
-140,381
-82% -$1.92M ﹤0.01% 3106
2025
Q2 		$2.1M Buy
+170,788
New +$2.48M 0.01% 1901
2025
Q1 		– Sell
-17,705
Closed -$402K – 3491
2024
Q4 		$402K Buy
+17,705
New +$386K ﹤0.01% 2608
2024
Q3 		– Sell
-12,765
Closed -$372K – 3336
2024
Q2 		$372K Sell
12,765
-4,438
-26% -$132K ﹤0.01% 2223
2024
Q1 		$610K Buy
+17,203
New +$688K ﹤0.01% 1904
2023
Q2 		– Sell
-80,518
Closed -$4.62M – 2358
2023
Q1 		$4.62M Buy
80,518
+75,251
+1,429% +$4.24M 0.06% 395
2022
Q4 		$295K Sell
5,267
-1,387
-21% -$70.6K ﹤0.01% 1514
2022
Q3 		$282K Sell
6,654
-812
-11% -$41.6K ﹤0.01% 2265
2022
Q2 		$403K Sell
7,466
-8,415
-53% -$505K 0.01% 1570
2022
Q1 		$1.02M Buy
+15,881
New +$1.05M 0.01% 1441
2021
Q3 		– Sell
-7,658
Closed -$523K – 2093
2021
Q2 		$523K Buy
+7,658
New +$542K ﹤0.01% 1068
2020
Q2 		– Sell
-11,552
Closed -$516K – 1103
2020
Q1 		$516K Buy
11,552
+7,277
+170% +$382K 0.02% 324
2019
Q4 		$249K Buy
+4,275
New +$254K ﹤0.01% 887
2019
Q2 		– Sell
-33,058
Closed -$1.84M – 1207
2019
Q1 		$1.84M Buy
+33,058
New +$1.68M 0.07% 228
2018
Q3 		– Sell
-14,058
Closed -$905K – 1337
2018
Q2 		$905K Buy
+14,058
New +$871K 0.06% 452
2017
Q2 		– Sell
-9,700
Closed -$409K – 1094
2017
Q1 		$409K Buy
+9,700
New +$414K 0.04% 682
2016
Q4 		– Sell
-5,630
Closed -$232K – 1269
2016
Q3 		$232K Buy
+5,630
New +$236K 0.02% 912

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Verition Fund Management's IART Position: Q2 2026 in Review

Verition Fund Management sold out of Integra LifeSciences (IART) in Q2 2026, closing a stake of 17,116 shares — an estimated $161K sold.

Verition Fund Management first reported a position in IART in Q3 2016 and held it in 19 quarters. The position peaked at $4.62M in Q1 2023. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Verition Fund Management reported no remaining Integra LifeSciences position as of Q2 2026 after selling out during the quarter.
  • Verition Fund Management sold 17,116 Integra LifeSciences shares in Q2 2026, an estimated $161K.
  • Verition Fund Management first reported a position in Integra LifeSciences in Q3 2016 and held it in 19 quarters.
  • Verition Fund Management's Integra LifeSciences position peaked at $4.62M in Q1 2023.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.